company background image
300357 logo

Zhejiang Wolwo Bio-Pharmaceutical XSEC:300357 Stock Report

Last Price

CN¥22.18

Market Cap

CN¥11.6b

7D

-5.4%

1Y

-26.0%

Updated

23 Nov, 2024

Data

Company Financials +

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

XSEC:300357 Stock Report

Market Cap: CN¥11.6b

300357 Stock Overview

A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. More details

300357 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends4/6

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Wolwo Bio-Pharmaceutical
Historical stock prices
Current Share PriceCN¥22.18
52 Week HighCN¥30.30
52 Week LowCN¥16.32
Beta0.68
11 Month Change-11.17%
3 Month Change30.78%
1 Year Change-25.99%
33 Year Change-60.75%
5 Year Change-51.70%
Change since IPO-4.56%

Recent News & Updates

Recent updates

Shareholder Returns

300357CN PharmaceuticalsCN Market
7D-5.4%-1.5%-2.1%
1Y-26.0%-9.4%2.8%

Return vs Industry: 300357 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 300357 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 300357's price volatile compared to industry and market?
300357 volatility
300357 Average Weekly Movement10.9%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 300357's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300357's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20021,709Gengxi Huwww.wolwobiotech.com

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Wolwo Bio-Pharmaceutical's earnings and revenue compare to its market cap?
300357 fundamental statistics
Market capCN¥11.61b
Earnings (TTM)CN¥312.29m
Revenue (TTM)CN¥904.64m

37.2x

P/E Ratio

12.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300357 income statement (TTM)
RevenueCN¥904.64m
Cost of RevenueCN¥43.86m
Gross ProfitCN¥860.78m
Other ExpensesCN¥548.49m
EarningsCN¥312.29m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.60
Gross Margin95.15%
Net Profit Margin34.52%
Debt/Equity Ratio1.5%

How did 300357 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

31%

Payout Ratio